Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells
- PMID: 15688382
- DOI: 10.1002/ijc.20884
Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells
Abstract
Naturally occurring molecules with putative cancer chemopreventive properties such as the phytoalexin resveratrol (3,5,4'-trihydroxystilbene) are lead molecules that guide the design of novel agents with improved pharmacologic properties. The synthetic resveratrol analog 3,4,5,4'-tetramethoxystilbene (DMU-212) has been shown to possess stronger antiproliferative properties in human colon cancer cells than resveratrol. We tested the hypothesis that DMU-212 is also a more potent inhibitor of adenoma development in the Apc(Min+) mouse, a model of human intestinal carcinogenesis. Apc(Min+) mice received either stilbene derivative with the diet (0.2%), and adenomas were counted after experiments were terminated. Resveratrol and DMU-212 decreased adenoma load by 27% and 24%, respectively, compared to untreated controls. Cyclooxygenase (COX) enzymes are important mechanistic targets of resveratrol, and we investigated whether DMU-212 interferes with the expression and activity of COX in human colon cells. Incubation of HCA-7 cancer cells for 24-96 hr with either stilbene derivative (1-50 microM) decreased prostaglandin E-2 (PGE-2) production, but only resveratrol decreased COX-2 protein expression. In mice, which received either stilbene derivative (0.2%) for 3 weeks with their diet, PGE-2 levels in the intestinal mucosa were reduced by between 45% and 62% compared to mice on control diet. While resveratrol inhibited enzyme activity in purified COX preparations, DMU-212 failed to do so. The PGE-2 decrease seen with DMU-212 in cells and in vivo is probably mediated via its metabolites. The results suggest that alteration of the resveratrol molecule to generate DMU-212 does not abrogate its ability to decrease adenoma number in Apc(Min+) mice or to interfere with PGE-2 generation in cells.
Copyright 2005 Wiley-Liss, Inc
Similar articles
-
The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice.Mol Cancer Ther. 2005 Sep;4(9):1287-92. doi: 10.1158/1535-7163.MCT-05-0165. Mol Cancer Ther. 2005. PMID: 16170019
-
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.Br J Cancer. 2004 Feb 9;90(3):736-44. doi: 10.1038/sj.bjc.6601568. Br J Cancer. 2004. PMID: 14760392 Free PMC article.
-
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.Cancer Res. 2000 Apr 1;60(7):1864-70. Cancer Res. 2000. PMID: 10766173
-
Resveratrol: one molecule, many targets.IUBMB Life. 2008 May;60(5):323-32. doi: 10.1002/iub.47. IUBMB Life. 2008. PMID: 18421779 Review.
-
The potential of resveratrol against human gliomas.Anticancer Drugs. 2010 Feb;21(2):140-50. doi: 10.1097/CAD.0b013e32833498f1. Anticancer Drugs. 2010. PMID: 20010425 Review.
Cited by
-
Resveratrol and cancer: focus on in vivo evidence.Endocr Relat Cancer. 2014 May 6;21(3):R209-25. doi: 10.1530/ERC-13-0171. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24500760 Free PMC article. Review.
-
Cytotoxic, tubulin-interfering and proapoptotic activities of 4'-methylthio-trans-stilbene derivatives, analogues of trans-resveratrol.Cytotechnology. 2018 Oct;70(5):1349-1362. doi: 10.1007/s10616-018-0227-3. Epub 2018 May 28. Cytotechnology. 2018. PMID: 29808373 Free PMC article.
-
The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.Cell Death Dis. 2014 Nov 20;5(11):e1533. doi: 10.1038/cddis.2014.486. Cell Death Dis. 2014. PMID: 25412311 Free PMC article.
-
Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials.Nutrients. 2023 Apr 14;15(8):1896. doi: 10.3390/nu15081896. Nutrients. 2023. PMID: 37111115 Free PMC article. Review.
-
CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues.Molecules. 2024 Jan 15;29(2):423. doi: 10.3390/molecules29020423. Molecules. 2024. PMID: 38257336 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials